Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 4
2005 5
2006 7
2007 5
2008 16
2009 17
2010 19
2011 27
2012 30
2013 19
2014 20
2015 23
2016 23
2017 18
2018 11
2019 7
2020 6
2021 8
2022 3
2023 3
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Atazanavir / ritonavir versus Lopinavir / ritonavir-based combined antiretroviral therapy (cART) for HIV-1 infection: a systematic review and meta-analysis.
Tigabu BM, Agide FD, Mohraz M, Nikfar S. Tigabu BM, et al. Afr Health Sci. 2020 Mar;20(1):91-101. doi: 10.4314/ahs.v20i1.14. Afr Health Sci. 2020. PMID: 33402897 Free PMC article.
CONCLUSION: Atazanavir/ritonavir has a better viral suppression at lower risk of lipid abnormality than lopinavir/ritonavir. The risk and development of hyperbilirubinemia from atazanavir-based regimens should be taken into consideration both at the time of prescrib …
CONCLUSION: Atazanavir/ritonavir has a better viral suppression at lower risk of lipid abnormality than lopinavir/ritonavir. The risk …
Atazanavir pharmacokinetics, efficacy and safety in pregnancy: a systematic review.
Eley T, Bertz R, Hardy H, Burger D. Eley T, et al. Antivir Ther. 2013;18(3):361-75. doi: 10.3851/IMP2473. Epub 2012 Nov 26. Antivir Ther. 2013. PMID: 23676668
BACKGROUND: For some antiretroviral therapies, drug concentrations are reduced during pregnancy, potentially compromising effective virological suppression. METHODS: Data on atazanavir boosted with ritonavir in pregnancy are reviewed. RESULTS: With standard atazanavir …
BACKGROUND: For some antiretroviral therapies, drug concentrations are reduced during pregnancy, potentially compromising effective virologi …
Efficacy and safety of atazanavir/ritonavir-based antiretroviral therapy for HIV-1 infected subjects: a systematic review and meta-analysis.
Menshawy A, Ismail A, Abushouk AI, Ahmed H, Menshawy E, Elmaraezy A, Gadelkarim M, Abdel-Maboud M, Attia A, Negida A. Menshawy A, et al. Arch Virol. 2017 Aug;162(8):2181-2190. doi: 10.1007/s00705-017-3346-9. Epub 2017 Mar 30. Arch Virol. 2017. PMID: 28361290
Atazanavir (ATZ) is a well-tolerated protease inhibitor that can be boosted with ritonavir (r) to treat infection with resistant strains of human immunodeficiency virus 1 (HIV-1). ...
Atazanavir (ATZ) is a well-tolerated protease inhibitor that can be boosted with ritonavir (r) to treat infection with resistant stra …
Pharmacokinetic-pharmacodynamic modelling of atazanavir in hair among adolescents on antiretroviral treatment in Zimbabwe.
Ngara B, Zvada S, Chawana TD, Nhachi CFB, Rusakaniko S. Ngara B, et al. BMC Pharmacol Toxicol. 2021 May 24;22(1):29. doi: 10.1186/s40360-021-00497-8. BMC Pharmacol Toxicol. 2021. PMID: 34030726 Free PMC article. Clinical Trial.
The objective of our study is to determine potency of atazanavir in hair, defined as atazanavir level in hair associated with 50% probability of failing to achieve viral load below 1000 copies/ml among adolescents, and explore the effect of participant specific vari …
The objective of our study is to determine potency of atazanavir in hair, defined as atazanavir level in hair associated with …
Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients.
Kalantari S, Fard SR, Maleki D, Taher MT, Yassin Z, Alimohamadi Y, Minaeian S. Kalantari S, et al. J Med Virol. 2021 Dec;93(12):6557-6565. doi: 10.1002/jmv.27195. Epub 2021 Jul 28. J Med Virol. 2021. PMID: 34255369 Free PMC article. Clinical Trial.
The purpose of this study was to compare the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients based on clinical and laboratory parameters. ...Patients were randomly assi …
The purpose of this study was to compare the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Rito …
A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after induction.
Baril J, Conway B, Giguère P, Ferko N, Hollmann S, Angel JB. Baril J, et al. HIV Med. 2014 May;15(5):301-10. doi: 10.1111/hiv.12118. Epub 2013 Dec 9. HIV Med. 2014. PMID: 24314017 Free article.

HIV RNA < 50 copies/mL) between PI/RTV and unboosted atazanavir [RR = 1.04; 95% confidence interval (CI) 0.99 to 1.10], with no heterogeneity. Findings were similar in a subanalysis of studies where atazanavir/RTV was the only PI/RTV used during induction. Additi

…

HIV RNA < 50 copies/mL) between PI/RTV and unboosted atazanavir [RR = 1.04; 95% confidence interval (CI) 0.99 to 1.10], with no he

…
Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials.
Carey D, Amin J, Boyd M, Petoumenos K, Emery S. Carey D, et al. J Antimicrob Chemother. 2010 Sep;65(9):1878-88. doi: 10.1093/jac/dkq231. Epub 2010 Jun 16. J Antimicrob Chemother. 2010. PMID: 20554568
OBJECTIVES: To compare lipid profiles in HIV-infected adults receiving atazanavir-based regimens. METHODS: We conducted a systematic review of randomized controlled trials (RCTs) comparing atazanavir or atazanavir/ritonavir with a comparator and evaluated lip …
OBJECTIVES: To compare lipid profiles in HIV-infected adults receiving atazanavir-based regimens. METHODS: We conducted a systematic …
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir.
Martinez E, Gonzalez-Cordon A, Ferrer E, Domingo P, Negredo E, Gutierrez F, Portilla J, Curran A, Podzamczer D, Murillas J, Bernardino JI, Santos I, Carton JA, Peraire J, Pich J, Perez I, Gatell JM; ATADAR Study Group. Martinez E, et al. HIV Med. 2014 Jul;15(6):330-8. doi: 10.1111/hiv.12121. Epub 2014 Jan 12. HIV Med. 2014. PMID: 24417772 Free article. Clinical Trial.
The extent to which lipid effects and overall tolerability differ between treatments with atazanavir and darunavir and whether atazanavir-induced hyperbilirubinaemia may result in more favourable metabolic effects are issues that remain to be resolved. ...However, t …
The extent to which lipid effects and overall tolerability differ between treatments with atazanavir and darunavir and whether ata …
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial.
Fabbiani M, Gagliardini R, Ciccarelli N, Quiros Roldan E, Latini A, d'Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Del Pin B, Lombardi F, D'Avino A, Focà E, Colafigli M, Cauda R, Di Giambenedetto S, De Luca A; ATLAS-M Study Group. Fabbiani M, et al. J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123. J Antimicrob Chemother. 2018. PMID: 29668978 Clinical Trial.
OBJECTIVES: To investigate the long-term safety and efficacy of a treatment switch to dual ART with atazanavir/ritonavir + lamivudine versus continuing a standard regimen with atazanavir/ritonavir + 2NRTI in virologically suppressed patients. ...CONCLUSIONS: In this …
OBJECTIVES: To investigate the long-term safety and efficacy of a treatment switch to dual ART with atazanavir/ritonavir + lamivudine …
Systematic Literature Review and Meta-Analysis of Renal Function in Human Immunodeficiency Virus (HIV)-Infected Patients Treated with Atazanavir (ATV)-Based Regimens.
Cure S, Bianic F, Espinas C, Hardy H, Rosenblatt L, Juday T. Cure S, et al. PLoS One. 2015 May 4;10(5):e0124666. doi: 10.1371/journal.pone.0124666. eCollection 2015. PLoS One. 2015. PMID: 25938588 Free PMC article.
The objective of this study was to evaluate the relative impact of atazanavir (ATV)-based regimens on the renal function of adult patients with HIV. We conducted a systematic literature review by searching PubMed, EMBASE, Cochrane library, and the CRD from 2000 until March …
The objective of this study was to evaluate the relative impact of atazanavir (ATV)-based regimens on the renal function of adult pat …
243 results